This presentation provided a comprehensive overview of the FDA’s medical device presubmission process, a critical step for manufacturers seeking to efficiently bring safe and effective devices to market. This session examined the strategic advantages of utilizing the presubmission program (Q-Sub), outlining key components and benefits.
